Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 27, 2013		Sep. 27, 2013
Current assets:
Cash and cash equivalents	$ 484,640		$ 454,397
Restricted cash	3,349		3,175
Short-term investments	179,406		140,267
Accounts receivable, net of allowance of $901 at December 27, 2013 and $514 at September 27, 2013	75,949		97,460
Inventories	8,253		10,093
Deferred taxes	81,630		84,238
Prepaid expenses and other current assets	25,584		28,949
Total current assets	858,811		818,579
Long-term investments	293,719	[1]	306,338	[1]
Property, plant and equipment, net	243,712		242,917
Intangible assets, net	37,996		41,315
Goodwill	279,059		279,724
Deferred taxes	41,265		37,434
Other non-current assets	11,063		11,638
Total assets	1,765,625		1,737,945
Current liabilities:
Accounts payable	7,490		10,695
Accrued liabilities	124,964		137,795
Income taxes payable	2,412		3,394
Deferred revenue	15,165		20,931
Total current liabilities	150,031		172,815
Long-term deferred revenue	19,532		19,663
Other non-current liabilities	46,292		45,441
Total liabilities	215,855		237,919
Stockholders' equity:
Additional paid-in capital	23,594		18,812
Retained earnings	1,498,897		1,454,382
Accumulated other comprehensive income	7,385		7,814
Total stockholders’ equity – Dolby Laboratories, Inc.	1,529,979		1,481,110
Controlling interest	19,791		18,916
Total stockholders’ equity	1,549,770		1,500,026
Total liabilities and stockholders’ equity	1,765,625		1,737,945
Class A Common Stock [Member]
Stockholders' equity:
Common stock	49		47
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 54		$ 55

[1] Our long-term investments have maturities that range from one to three years.